the future of glp 1 drugs Didn't take much for time magazine to do a flip! From “The big promise” to “A metabolic whiplash” A new study came out yesterday that showed that stopping GLP-1 for GLP-1 drugs, even when they
Description
, decreased
Stephanie Widmer, a board-certified physician in emergency medicine, toxicology, and addiction medicine
PMID: 38017205
He worked on a study last year that found that taking a GLP-1 was linked to reduced risk of developing cancer
GLP-1s are typically prescribed at a higher dose for obesity than for diabetes
At microdose levels, this risk is likely minimal, but patients with existing gallbladder disease should be monitored
